Form 4 for STLN Starling Oncology, Inc.
Accepted 2026-08-17 10:13:13 ET · period of report 2026-08-13 · accession 0000921895-26-002203 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-17 10:13 | 2026-08-14 | STLN | Chernett Jorey | 10% | P - Purchase | $6.54 | +12.0K | 10.66M | +0.1% | +$78.5K |
| D | 2026-08-17 10:13 | 2026-08-13 | STLN | Chernett Jorey | 10% | S - Sale | $6.24 | -100 | 0 | -100% | -$624 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-14 | P | A | 12,000 | $6.54 | 10,660,858 | D | — | — | |
| 2 | Derivative | Call Option (STLN 19FEB27 $9C) | 2026-08-13 | S | D | 100 | $6.24 | 0 | D | $9.00 · 2026-08-13 to 2027-02-19 | 10,000 Common Stock | (F1) The sale of these call options is a matchable transaction subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. |